People taking Definium Therapeutics' DT120 showed long-lasting reductions in their depression symptoms compared to a placebo, ...
Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six prospective controlled studies that included 3,532 ...
An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...
Bullfrog AI Holdings, Inc. BFRG shares are trading higher on continued strength Tuesday after the company announced a commercial agreement on Monday with a top five global pharmaceutical company to ...
BURLINGTON, Mass. and JERUSALEM, Sept. 16, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results